Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Heart Disease Mortality in Cancer Survivors: A Population-Based Study in Japan.

Journal of the American Heart Association·2023
Same author

RGMa collapses the neuronal actin barrier against disease-implicated protein and exacerbates ALS.

Science advances·2023
Same author

Analysis of gut microbiome, host genetics, and plasma metabolites reveals gut microbiome-host interactions in the Japanese population.

Cell reports·2023
Same author

Comparison of surgical outcomes between iStent inject W implantation and microhook ab interno trabeculotomy in combination with phacoemulsification in primary open-angle glaucoma patients.

Frontiers in medicine·2023
Same author

Correction: Continuous Subcutaneous Foslevodopa/Foscarbidopa in Parkinson's Disease: Safety and Efficacy Results From a 12-Month, Single-Arm, Open-Label, Phase 3 Study.

Neurology and therapy·2023
Same author

Extracellular high molecular weight α-synuclein oligomers induce cell death by disrupting the plasma membrane.

NPJ Parkinson's disease·2023

Related Experiment Video

Updated: Jun 26, 2026

Mating-based Overexpression Library Screening in Yeast
11:39

Mating-based Overexpression Library Screening in Yeast

Published on: July 6, 2018

Parkin gene therapy.

Hideki Mochizuki1

  • 1Department of Neurology, Juntendo University School Medicine 2-1-1, Hongo, Bunkyo-ku, Tokyo 113-8421, Japan. hideki@med.juntendo.ac.jp

Parkinsonism & Related Disorders
|January 10, 2009
PubMed
Summary

Genetic mutations in Parkinson's disease (PD) are being identified. Parkin gene therapy shows promise for treating PD, potentially benefiting patients with alpha-synuclein gene mutations and offering a novel therapeutic approach.

Area of Science:

  • Neuroscience
  • Genetics
  • Molecular Biology

Background:

  • Familial Parkinson's disease (PD) research has identified several causative genes and loci.
  • Mutations in the parkin gene are associated with autosomal recessive juvenile parkinsonism.
  • While genetic PD forms are rare, gene therapy offers potential for idiopathic PD.

Purpose of the Study:

  • To explore the potential of gene therapy for Parkinson's disease.
  • To investigate parkin gene therapy's efficacy, particularly in relation to alpha-synuclein mutations.
  • To assess parkin's role in correcting neuronal degeneration in PD.

Main Methods:

  • Literature review of genetic studies in Parkinson's disease.
  • Analysis of gene therapy approaches targeting key PD pathways.

More Related Videos

Limbal Approach-Subretinal Injection of Viral Vectors for Gene Therapy in Mice Retinal Pigment Epithelium
06:48

Limbal Approach-Subretinal Injection of Viral Vectors for Gene Therapy in Mice Retinal Pigment Epithelium

Published on: August 7, 2015

Isolation of Next-Generation Gene Therapy Vectors through Engineering, Barcoding, and Screening of Adeno-Associated Virus (AAV) Capsid Variants
09:20

Isolation of Next-Generation Gene Therapy Vectors through Engineering, Barcoding, and Screening of Adeno-Associated Virus (AAV) Capsid Variants

Published on: October 18, 2022

Related Experiment Videos

Last Updated: Jun 26, 2026

Mating-based Overexpression Library Screening in Yeast
11:39

Mating-based Overexpression Library Screening in Yeast

Published on: July 6, 2018

Limbal Approach-Subretinal Injection of Viral Vectors for Gene Therapy in Mice Retinal Pigment Epithelium
06:48

Limbal Approach-Subretinal Injection of Viral Vectors for Gene Therapy in Mice Retinal Pigment Epithelium

Published on: August 7, 2015

Isolation of Next-Generation Gene Therapy Vectors through Engineering, Barcoding, and Screening of Adeno-Associated Virus (AAV) Capsid Variants
09:20

Isolation of Next-Generation Gene Therapy Vectors through Engineering, Barcoding, and Screening of Adeno-Associated Virus (AAV) Capsid Variants

Published on: October 18, 2022

  • Examination of studies investigating parkin gene function and its therapeutic potential.

    • Main Results:

    • Several genes and loci linked to familial Parkinson's disease have been identified.
    • Parkin gene mutations are a known cause of autosomal recessive juvenile parkinsonism.
    • Emerging evidence suggests parkin gene therapy may benefit PD patients with alpha-synuclein mutations.

    Conclusions:

    • Parkin gene therapy is a potential therapeutic strategy for Parkinson's disease.
    • This approach may be particularly effective for a subset of PD patients with alpha-synuclein gene mutations.
    • Parkin overexpression could potentially correct neuronal degeneration, offering a novel treatment for alpha-synucleinopathy.